This project seeks to address the increasing risk of overdose death, substance use disorder (SUD), and opioid use disorder (OUD) in adolescents. The investigators believe that pediatric primary care providers (PCP) could play an important role in helping youth with SUD because most adolescents see their PCPs for annual wellness visits. However, PCPs have many barriers to treating their young patients with SUD/OUD: lack of training, resources, and support to deliver SUD/OUD services, limited time with patients, and the only available referral options often come with long wait times for an appointment. Through this project, the investigators will build upon an existing Integrated Behavioral Health (IBH) system by offering stigma-reduction interventions and brief SUD interventions within primary care settings. The goal of this project is to learn if clinics participating in an Integrated Behavioral Healthcare Program with SUD resources will increase delivery of effective adolescent SUD care and ultimately lead to better health outcomes when compared to standard primary care treatment. During the first project phase, the research team will gather a Parent and Youth Advisory Board, Primary Care Provider Advisory Board, and Integrated Care Expert Panel (Aim 1) to inform the development and refinement of the primary care-based SUD interventions. The investigators will gather input from national experts, local stakeholders, and PCPs to refine our screening to treatment approach (Aim 2), coupled with stigma reduction activities, within pediatric primary care. During the second project phase, researchers will assess the impact of SUD IBH on PCP behaviors around adolescent SUD intervention. The investigators will interview and survey PCPs, clinic managers, and other clinical staff for willingness to engage in adolescent SUD treatment. The investigators will evaluate implementation outcomes (views toward SUD, stigma attitudes, IBH team dynamics; Aim 3) and effectiveness/reach outcomes (delivery of integrated primary care-based SUD services, the use of brief interventions for adolescents, number of consultation calls, and increased treatment engagement; Aim 4a), along with an exploratory test of local overdose rates for youth (Aim 4b), in order to examine local effects of the new intervention. This project is supported by the HEAL Initiative (https://heal.nih.gov/).
Age range
12 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Evidence-Based Practice Attitudes Scale
Timeframe: Surveys will be collected prior to implementation, then continue every six months for a total of 1 year.
Primary Care Team Dynamics Survey
Timeframe: Surveys will be collected prior to implementation, then continue every six months for a total of 1 year.
Implementation Leadership and Climate Scale
Timeframe: Surveys will be collected prior to implementation, then continue every six months for a total of 1 year.
Attribution Questionnaire - SUD
Timeframe: Surveys will be collected prior to implementation, then continue every six months for a total of 1 year.
Attitudes of Medication Opioid Use Disorder (MOUD) Treatment
Timeframe: Surveys will be collected prior to implementation, then continue every six months for a total of 1 year.
Acceptability of Intervention, Intervention Appropriateness Measure, Feasibility of Intervention Measure
Timeframe: Surveys will be collected prior to implementation, then continue every six months for a total of 1 year.
Confidence, Barriers, and Feedback
Timeframe: Surveys will be collected prior to implementation, then continue every six months for a total of 1 year.
Provider Report of Sustainment Scale
Timeframe: Surveys will be collected prior to implementation, then continue every six months for a total of 1 year.
Systems Usability Scale
Timeframe: Surveys will be collected prior to implementation, then continue every six months for a total of 1 year.
Stages of Implementation Completion (SIC)
Timeframe: From baseline through study completion, an average of 5 years
Screening Rates
Timeframe: From clinical trial launch, data will be collected twice a year, for a total of four years.
Referral Rates
Timeframe: From clinical trial launch, data will be collected twice a year, for a total of four years.
Brief Substance Use Disorder (SUD) Treatment Engagement
Timeframe: From clinical trial launch, data will be collected twice a year, for a total of four years.
Comprehensive SUD Treatment Engagement
Timeframe: From clinical trial launch, data will be collected twice a year, for a total of four years.
MOUD Prescription
Timeframe: From clinical trial launch, data will be collected twice a year, for a total of four years.
Provider 2 Provider (P2P) Consultation Calls
Timeframe: From clinical trial launch, data will be collected twice a year, for a total of four years.